Tel Aviv 60 Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
Current Valuation | Efficiency | Market Risk | Exp Return | ||||
---|---|---|---|---|---|---|---|
1 | SLGN | Silgan Holdings | 0.15 | 1.09 | 0.16 | ||
2 | PEN | Penumbra | 0.14 | 2.31 | 0.33 | ||
3 | LEVI | Levi Strauss Co | (0.12) | 1.75 | (0.21) | ||
4 | VCTR | Victory Capital Holdings | 0.17 | 2.24 | 0.38 | ||
5 | ELLO | Ellomay Capital | 0.12 | 3.14 | 0.37 | ||
6 | KMDA | Kamada | 0.03 | 1.67 | 0.05 | ||
7 | ALLT | Allot Communications | 0.10 | 3.69 | 0.37 | ||
8 | INCR | INC Research Holdings | (0.13) | 4.52 | (0.60) | ||
9 | LCTX | Lineage Cell Therapeutics | (0.14) | 5.35 | (0.77) | ||
10 | RANI | Rani Therapeutics Holdings | (0.01) | 9.99 | (0.14) | ||
11 | PRTC | PureTech Health PLC | 0.01 | 3.33 | 0.02 | ||
12 | CGEN | Compugen | (0.15) | 3.52 | (0.52) | ||
13 | VTNA | Vetanova | 0.00 | 0.00 | 0.00 | ||
14 | ELWS | Earlyworks Co, Ltd | 0.06 | 11.92 | 0.67 | ||
15 | MRIN | Marin Software | (0.10) | 2.65 | (0.26) | ||
16 | ORMP | Oramed Pharmaceuticals | (0.02) | 2.34 | (0.06) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.